Clopidogrel
Active substance: clopidogrel bisulfate
TABLET · CLOPIDOGREL BISULFATE 300 mg/1
United StatesActive
Marketing holder: Vensun Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CLOPIDOGREL BISULFATE · 300 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3881-749b-bdc5-fab4881fa197,01a1208c-48b1-783a-8d63-0c1597fbf27f,01a1208c-5b16-734f-b640-e13718c02d0f,01a1208c-5be9-75e7-a3cd-67711a9cf02e,01a1208c-7af0-707b-9850-a4fbf93b6331;count=64 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42543-714
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42543-714 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42543-714 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42543-714 · Verified 2026-10-09 · open in source